Alemtuzumab

Also known as CAMPATH is a Monoclonal antibody used in treating certain hematologic malignancies. Its mechanism of action is based on binding CD52 on cells and resulting in lysis. Note: Drugs ending with "MAB" are "Monoclonal AntiBodies".